Spotlight
Video

gefitinib versus placebo in esophageal cancer progressing after chemotherapy (COG)

feeds has 409 videos Subscribe Here

Loading........
Description: Vienna, ESMO 2012, Pressconference September 29: Prof. David Ferry, Medical Oncology, Russells Hall Hospital, Dudley/UNITED KINGDOM
Phase III multi-centre, randomised, double-blind, placebo-controlled parallel arm trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy on behalf of the COG (Cancer Oesophagus Gefitinib) Collaborative Group.
Shared By : feeds
Posted on : 10/02/12
Added : 5 years ago
Category : Other



More From feeds

Nothing found.